Results 181 to 190 of about 676,629 (244)

Insight to Neglected Biomarkers in COVID-19: A Comprehensive Narrative Review". [PDF]

Biomark Insights
Jalilian S, Bastani MN, Afsharzadeh F.
europepmc   +1 more source

Tetranectin: Molecular Mechanisms, Biological Functions and Clinical Implications. [PDF]

Int J Mol Sci
Ahmed S, Iram S, Akash A, Kim K, Kim J.
europepmc   +1 more source

Soluble urokinase plasminogen activator receptor and perioperative complications: a systematic review. [PDF]

BMC Anesthesiol
Gungor AB, Pennathur P, Guran HS, Chu W, Roshanov PS.   +4 more
europepmc   +1 more source

Profibrinolytic Factors and Cancer Progression, Metastasis, and Survival. [PDF]

Arterioscler Thromb Vasc Biol
Hisada Y, Mackman N.
europepmc   +1 more source

Plasma suPAR and domain-specific cognitive performance in virologically suppressed women with HIV. [PDF]

J Neurovirol
Gonzalez H, Ridgeway K, Shorer EF, Dastgheyb R, Rajagopal R, Cao Y, Morack R, Hahm E, Weber KM, Rubin LH, French AL.   +10 more
europepmc   +1 more source

Cholecystokinin A Receptor Knockdown Diminishes Colon Cancer Cell Invasive Potential via Modulation of Integrin/FAK, EMT, and uPA/uPAR/MMP2 Axis. [PDF]

Oncol Res
Lin CS, Hsu TW, Lee HL, Kao SH.
europepmc   +1 more source

The role of suPAR and related proteins in kidney, heart diseases, and diabetes. [PDF]

J Clin Invest
Reiser J, Hayek SS, Sever S.
europepmc   +1 more source

IL-17RA/RC blockade modulates the fibrinolytic system and MMP activity in bleomycin-induced pulmonary fibrosis in male mice. [PDF]

Physiol Rep
Charavu R, Madambath JT, Jain AB, Bhandary YP.   +3 more
europepmc   +1 more source

Differentiating borderline HER2-expressing and HER2-positive cancers from other subtypes using serum urokinase plasminogen activator. [PDF]

Br J Cancer
López Mujica MEJ, Boonkaew S, Christensen NL, Abildgaard Pedersen M, Riegels Jørgensen K, Holm Vendelbo M, Ferapontova EE.   +6 more
europepmc   +1 more source